Actinium Pharmaceuticals (ATNM) Other Operating Expenses (2010 - 2017)
Actinium Pharmaceuticals (ATNM) posted quarterly Other Operating Expenses of -$46303.0 for Q4 2017, up 19.71% year-over-year from -$38679.2 in Q4 2016, and down 519.11% quarter-over-quarter from $11048.0 in Q3 2017.
Actinium Pharmaceuticals (ATNM) Other Operating Expenses (2010 - 2017) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Other Operating Expenses for 8 consecutive years, with -$46303.0 the latest figure, recorded in Q4 2017.
- In Q4 2017, Other Operating Expenses rose 19.71% year-over-year to -$46303.0; the TTM figure through Sep 2018 stood at -$46303.0 (down 307.35% YoY), while the FY2015 annual figure was $53465.0, up 41.04% from the prior year.
- Other Operating Expenses eased to -$46303.0 in Q4 2017 per ATNM's latest filing, from $11048.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $1.6 million in Q1 2014 and bottomed at -$57670.0 in Q4 2016.
- Historically, Other Operating Expenses has averaged $98648.6 across 5 years, with a median of $14326.0 in 2014.
- Annual changes were most pronounced in 2014 — Other Operating Expenses jumped 38702.16% — and 2016, when it tumbled 673.49%.
- Actinium Pharmaceuticals' Other Operating Expenses stood at -$4122.0 in 2013, then jumped by 442.67% to $14125.0 in 2014, then slipped by 28.81% to $10056.0 in 2015, then sank by 673.49% to -$57670.0 in 2016, then increased by 19.71% to -$46303.0 in 2017.
- Business Quant data shows ATNM's Other Operating Expenses at -$46303.0 in Q4 2017, $11048.0 in Q3 2017, and $14335.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Actinium Pharmaceuticals | 35.01 Mn | 35.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -46,303.00 |
| Sep 30, 2017 | 11,048.00 |
| Jun 30, 2017 | 14,335.00 |
| Mar 31, 2017 | 20,920.00 |
| Dec 31, 2016 | -57,670.00 |
| Sep 30, 2016 | 20,078.00 |
| Jun 30, 2016 | 19,472.00 |
| Mar 31, 2016 | 18,120.00 |
| Dec 31, 2015 | 10,056.00 |
| Sep 30, 2015 | 16,820.00 |
| Jun 30, 2015 | 16,194.00 |
| Mar 31, 2015 | 10,395.00 |
| Dec 31, 2014 | 14,125.00 |
| Sep 30, 2014 | 14,326.00 |
| Jun 30, 2014 | 8,052.00 |
| Mar 31, 2014 | 1.59 Mn |
| Mar 31, 2013 | -4,122.00 |
| Sep 30, 2012 | -2,187.00 |
| Jun 30, 2012 | -1,225.00 |
| Mar 31, 2012 | -848.00 |